Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1993; Volume 43,Issue 3
  • You have access
    Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
    H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
    Molecular Pharmacology March 1993, 43 (3) 313-319;
  • You have access
    Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    F J Monsma, Y Shen, R P Ward, M W Hamblin and D R Sibley
    Molecular Pharmacology March 1993, 43 (3) 320-327;
  • You have access
    Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel.
    T A Kocarek, E G Schuetz and P S Guzelian
    Molecular Pharmacology March 1993, 43 (3) 328-334;
  • You have access
    N-hydroxylation of benzamidine to benzamidoxime by a reconstituted cytochrome P-450 oxidase system from rabbit liver: involvement of cytochrome P-450 IIC3.
    B Clement, F Jung and H Pfunder
    Molecular Pharmacology March 1993, 43 (3) 335-342;
  • You have access
    Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human.
    R F Thomas and S B Liggett
    Molecular Pharmacology March 1993, 43 (3) 343-348;
  • You have access
    Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
    J Akiyoshi, C Hough and D M Chuang
    Molecular Pharmacology March 1993, 43 (3) 349-355;
  • You have access
    Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
    T Kaneda, Y Kitamura and Y Nomura
    Molecular Pharmacology March 1993, 43 (3) 356-364;
  • You have access
    Histamine-induced production of interleukin-1 alpha from murine bone marrow stromal cells and its inhibition by H2 blockers.
    K Tasaka, M Mio, M Shimazawa and N Nakaya
    Molecular Pharmacology March 1993, 43 (3) 365-371;
  • You have access
    Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
    C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer
    Molecular Pharmacology March 1993, 43 (3) 372-379;
  • You have access
    A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.
    E A Austin and B E Huber
    Molecular Pharmacology March 1993, 43 (3) 380-387;
  • You have access
    Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes.
    P J Sausen, R J Duescher and A A Elfarra
    Molecular Pharmacology March 1993, 43 (3) 388-396;
  • You have access
    Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
    D Stickle and R Barber
    Molecular Pharmacology March 1993, 43 (3) 397-411;
  • You have access
    Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
    T Gudermann, F O Levy, M Birnbaumer, L Birnbaumer and A J Kaumann
    Molecular Pharmacology March 1993, 43 (3) 412-418;
  • You have access
    Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
    D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
    Molecular Pharmacology March 1993, 43 (3) 419-426;
  • You have access
    Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
    N Adham, B Ellerbrock, P Hartig, R L Weinshank and T Branchek
    Molecular Pharmacology March 1993, 43 (3) 427-433;
  • You have access
    Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
    D Graeser and R R Neubig
    Molecular Pharmacology March 1993, 43 (3) 434-443;
  • You have access
    Characterization of alpha 2-adrenergic receptor subtype-specific antibodies.
    H Kurose, J L Arriza and R J Lefkowitz
    Molecular Pharmacology March 1993, 43 (3) 444-450;
  • You have access
    Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
    M A Debernardi, R Munshi and G Brooker
    Molecular Pharmacology March 1993, 43 (3) 451-458;
  • You have access
    Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
    R A Hall, G Massicotte, M Kessler, M Baudry and G Lynch
    Molecular Pharmacology March 1993, 43 (3) 459-464;
  • You have access
    Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
    B D Carter and F Medzihradsky
    Molecular Pharmacology March 1993, 43 (3) 465-473;
  • You have access
    Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne
    Molecular Pharmacology March 1993, 43 (3) 474-481;
  • You have access
    Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
    N L Harrison, H K Radke, M M Tamkun and D M Lovinger
    Molecular Pharmacology March 1993, 43 (3) 482-486;
  • You have access
    Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
    J P Bolaños and J M Medina
    Molecular Pharmacology March 1993, 43 (3) 487-490;
  • You have access
    Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex.
    J M Rosenberg and P H Sato
    Molecular Pharmacology March 1993, 43 (3) 491-497;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 43, Issue 3
1 Mar 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics